[1]AppliedCatalysisA:General,2015,vol.492,p.76-82
[2]Patent:US2009/292141,2009,A1.Locationinpatent:Page/Pagecolumn4
[3]Patent:EP2364967,2011,A2.Locationinpatent:Page/Pagecolumn13
[4]Patent:US8741962,2014,B2.Locationinpatent:Page/Pagecolumn17
[5]OrganicProcessResearchandDevelopment,2014,vol.18,p.1169-1174
[6]Patent:US2011/218361,2011,A1.Locationinpatent:Page/Pagecolumn4-5
[7]Patent:WO2015/70995,2015,A1.Locationinpatent:Page/Pagecolumn27
[8]Patent:CN109180499,2019,A.Locationinpatent:Paragraph0073-0079;0080-0085
[9]Patent:WO2009/147432,2009,A1.Locationinpatent:Page/Pagecolumn14
[10]Patent:US2007/112217,2007,A1.Locationinpatent:Page/Pagecolumn13
[11]Patent:WO2009/122301,2009,A2.Locationinpatent:Page/Pagecolumn12
[12]Patent:WO2010/13048,2010,A1.Locationinpatent:Page/Pagecolumn10
[13]Patent:WO2010/59913,2010,A2.Locationinpatent:Page/Pagecolumn23-24
[14]Patent:WO2012/96635,2012,A1.Locationinpatent:Page/Pagecolumn7
[15]Patent:WO2012/153349,2012,A2.Locationinpatent:Page/Pagecolumn29
[16]Patent:WO2013/54346,2013,A2.Locationinpatent:Page/Pagecolumn13
[17]Patent:US2014/18578,2014,A1.Locationinpatent:Paragraph0031
[1]Patent:US2008/161408,2008,A1.Locationinpatent:Page/Pagecolumn3
[2]Patent:US2009/318564,2009,A1.Locationinpatent:Page/Pagecolumn4
[3]Patent:US2008/146676,2008,A1.Locationinpatent:Page/Pagecolumn1-2
[4]Patent:US2008/161408,2008,A1.Locationinpatent:Page/Pagecolumn2;3
[1]Patent:US2008/161408,2008,A1.Locationinpatent:Page/Pagecolumn3
[1]CurrentPatentAssignee:CIPLALTD-WO2009/81148,2009,A1Locationinpatent:Page/Pagecolumn12-13
Title: Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Journal: International journal of pharmaceutics 20121115
Title: Rasagiline: a guide to its use in Parkinson's disease.
Journal: CNS drugs 20120901
Title: Proteoliposome-based capillary electrophoresis for screening membrane protein inhibitors.
Journal: Journal of chromatographic science 20120801
Title: Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Journal: The International journal of neuroscience 20120701
Title: Drugs for treating Parkinson disease.
Journal: Nursing 20120701
Title: Development of Parkinson's disease in patients with Narcolepsy.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20120601
Title: Hyposmia in Parkinson's disease.
Journal: Psychiatry and clinical neurosciences 20120601
Title: Livedo reticularis associated with rasagiline (azilect).
Journal: Journal of drugs in dermatology : JDD 20120601
Title: The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
Journal: Journal of clinical pharmacology 20120501
Title: Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).
Journal: Bioorganic & medicinal chemistry 20120501
Title: Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20120401
Title: Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
Journal: Drugs 20120326
Title: Rasagiline interferes with neurodegeneration in the Prph2/rds mouse.
Journal: Retina (Philadelphia, Pa.) 20120301
Title: Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease.
Journal: European journal of neurology 20120201
Title: From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: Restless legs syndrome responsive to rasagiline treatment: a case report.
Journal: Clinical neuropharmacology 20120101
Title: Combined beneficial effect of rasagiline on motor function and depression in de novo PD.
Journal: Clinical neuropharmacology 20120101
Title: Drugs in traffic: the road to approval.
Journal: Nature medicine 20111206
Title: Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
Journal: European journal of neurology 20111201
Title: Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.
Journal: Movement disorders : official journal of the Movement Disorder Society 20111201
Title: Effect of rasagiline on the molecular composition of the excitatory postsynaptic density.
Journal: European journal of pharmacology 20111130
Title: Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline.
Journal: Movement disorders : official journal of the Movement Disorder Society 20111101
Title: Rasagiline: time to onset of antiparkinson effect is similar when used as a monotherapy or adjunct treatment.
Journal: The neurologist 20111101
Title: An effective novel delivery strategy of rasagiline for Parkinson's disease.
Journal: International journal of pharmaceutics 20111031
Title: Determining the efficacy of rasagiline in reducing bradykinesia among Parkinson's disease patients: a review.
Journal: The International journal of neuroscience 20110901
Title: The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
Journal: Movement disorders : official journal of the Movement Disorder Society 20110815
Title: Safety of rasagiline for the treatment of Parkinson's disease.
Journal: Expert opinion on drug safety 20110701
Title: TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure.
Journal: Circulation. Heart failure 20110701
Title: The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion.
Journal: British journal of pharmacology 20110601
Title: Defining meaningful outcome measures in trials of disease-modifying therapies in Parkinson's disease.
Journal: Expert opinion on pharmacotherapy 20110601
Title: A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
Journal: The Lancet. Neurology 20110501
Title: MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.
Journal: Journal of proteome research 20110401
Title: Determination of minimal clinically important change in early and advanced Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20110401
Title: Does 1-(R)-aminoindan possess neuroprotective properties against experimental Parkinson's disease?
Journal: Antioxidants & redox signaling 20110301
Title: Hemiparkinsonism-hemiatrophy syndrome.
Journal: Archives of Iranian medicine 20110301
Title: Rasagiline-induced serotonin syndrome.
Journal: Movement disorders : official journal of the Movement Disorder Society 20110301
Title: Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: An economic Markov model evaluation.
Journal: Drugs & aging 20110201
Title: MAO inhibitors.
Journal: Cleveland Clinic journal of medicine 20110201
Title: Rasagiline-induced delay of retinal ganglion cell death in experimental glaucoma in rats.
Journal: Journal of glaucoma 20110101
Title: Selegiline and rasagiline: twins or distant cousins?
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110101
Title: Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.
Journal: BMC pharmacology 20110101
Title: Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
Journal: Current medicinal chemistry 20110101
Title: [The role of the MAO-B inhibitor razagiline in the treatment of Parkinson's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
Title: Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease.
Journal: International review of neurobiology 20110101
Title: Rasagiline in Parkinson's disease.
Journal: International review of neurobiology 20110101
Title: Selective inhibitors of monoamine oxidase type B and the 'cheese effect'.
Journal: International review of neurobiology 20110101
Title: Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Journal: Journal of clinical pharmacology 20101201
Title: Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.
Journal: Neurochemical research 20101201
Title: The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
Journal: Neurology 20101123
Title: The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
Journal: Neurology 20101123
Title: Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.
Journal: Progress in neurobiology 20101101
Title: Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells.
Journal: Neurochemistry international 20101101
Title: [Rasagiline: effectiveness and protection in Parkinson's disease].
Journal: Revista de neurologia 20101101
Title: [Disease-modifying therapies in PD].
Journal: Rinsho shinkeigaku = Clinical neurology 20101101
Title: Efficacy and tolerability of rasagiline in daily clinical use--a post-marketing observational study in patients with Parkinson's disease.
Journal: European journal of neurology 20100901
Title: Isolated delusional syndrome in Parkinson's Disease.
Journal: Parkinsonism & related disorders 20100901
Title: Slowing the decline.
Journal: Nature 20100826
Title: Rasagiline improves learning and memory in young healthy rats.
Journal: Behavioural pharmacology 20100701
Title: Discordant effects of rasagiline doses in Parkinson disease.
Journal: Nature reviews. Neurology 20100701
Title: Long-term efficacy of rasagiline in early Parkinson's disease.
Journal: The International journal of neuroscience 20100601
Title: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?
Journal: Neurology 20100406
Title: The delayed-start study in Parkinson disease: can't satisfy everyone.
Journal: Neurology 20100406
Title: Reply to Drs. Olanow and Rascol.
Journal: Neurology 20100406
Title: The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline.
Journal: Journal of neurochemistry 20100301
Title: [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
Journal: Fortschritte der Neurologie-Psychiatrie 20100301
Title: Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression.
Journal: Nature reviews. Neurology 20100301
Title: Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.
Journal: The American journal of managed care 20100301
Title: Rasagiline in Parkinson's disease.
Journal: The New England journal of medicine 20100218
Title: Rasagiline in Parkinson's disease.
Journal: The New England journal of medicine 20100218
Title: TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.
Journal: The Journal of pharmacology and experimental therapeutics 20100201
Title: Selective MAO-B inhibitors have low potential for the tyramine effect.
Journal: Movement disorders : official journal of the Movement Disorder Society 20100115
Title: Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonism.
Journal: Neuro-degenerative diseases 20100101
Title: The role of rasagiline in the treatment of Parkinson's disease.
Journal: Clinical interventions in aging 20100101
Title: What is the clinical significance of the findings from the delayed-start trial of rasagiline in Parkinson's disease?
Journal: Neuroepidemiology 20100101
Title: Delayed start, rapid solution?
Journal: Neuroepidemiology 20100101
Title: Electropharmacograms of rasagiline, its metabolite aminoindan and selegiline in the freely moving rat.
Journal: Neuropsychobiology 20100101
Title: Treatment of advanced Parkinson's disease in the United States: a cost-utility model.
Journal: Clinical drug investigation 20100101
Title: [Rasagiline is not for all Parkinson disease patients: the ADAGIO study].
Journal: Nederlands tijdschrift voor geneeskunde 20100101
Title: [Efficacy of rasagiline in patients with advanced Parkinson's disease with motor fluctuation (azimut study)].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Title: Mao-B inhibitor know-how: back to the pharm.
Journal: Neurology 20091208
Title: Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20091113
Title: Genomic and proteomic study to survey the mechanism of action of the anti-Parkinson's disease drug, rasagiline compared with selegiline, in the rat midbrain.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20091101
Title: Rasagiline-induced spontaneous ejaculation.
Journal: Movement disorders : official journal of the Movement Disorder Society 20091030
Title: A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
Journal: The New England journal of medicine 20090924
Title: Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.
Journal: Neurotoxicity research 20090801
Title: Development and validation of a reverse phase liquid chromatography method for the quantification of rasagiline mesylate in biodegradable PLGA microspheres.
Journal: Journal of pharmaceutical and biomedical analysis 20090712
Title: Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20090415
Title: MAO-B inhibitor know-how: back to the pharm.
Journal: Neurology 20090414
Title: Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.
Journal: Neurotoxicity research 20090401
Title: Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20090315
Title: Neuroprotection by rasagiline in thiamine deficient rats.
Journal: Brain research 20090223
Title: Mechanisms compensating for dopamine loss in early Parkinson disease.
Journal: Neurology 20090217
Title: [Neuroprotection in Parkinson's disease and other neurodegenerative disorders: preclinical and clinical findings].
Journal: Ideggyogyaszati szemle 20090130
Title: Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20090101
Title: Investigation of oral selegiline and rasagiline administration on QT interval in conscious rabbits.
Journal: European review for medical and pharmacological sciences 20090101
Title: [Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101
Title: Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation.
Journal: Drugs & aging 20090101
Title: Sleep attack associated to rotigotine.
Journal: Clinical neuropharmacology 20090101
Title: Drug selection and timing of initiation of treatment in early Parkinson's disease.
Journal: Annals of neurology 20081201
Title: A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
Journal: Movement disorders : official journal of the Movement Disorder Society 20081115
Title: Rapid and sensitive liquid chromatography-tandem mass spectrometry: assay development, validation and application to a human pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081115
Title: The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy.
Journal: Expert opinion on pharmacotherapy 20081101
Title: Rasagiline ethanedisulfonate: an inhibitor for monoamine oxygenase B (MAO(B)).
Journal: Acta crystallographica. Section C, Crystal structure communications 20081101
Title: Validated LC-MS/MS method for quantitative determination of rasagiline in human plasma and its application to a pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081001
Title: [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Journal: Fortschritte der Neurologie-Psychiatrie 20081001
Title: Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease.
Journal: Hypertension (Dallas, Tex. : 1979) 20080901
Title: TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Journal: Journal of cardiovascular pharmacology 20080901
Title: Rasagiline in neurodegeneration.
Journal: Experimental neurology 20080801
Title: Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
Journal: Journal of neurochemistry 20080601
Title: [Rasagiline in Parkinson's disease].
Journal: Neurologia (Barcelona, Spain) 20080501
Title: Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
Journal: Experimental neurology 20080401
Title: [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
Journal: Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20080301
Title: Rasagiline improves freezing in a patient with primary progressive freezing gait.
Journal: Movement disorders : official journal of the Movement Disorder Society 20080215
Title: Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors.
Journal: Journal of biomolecular structure & dynamics 20080201
Title: Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20080101
Title: [The use of a new MAO B inhibitor rasagiline in the treatment of motor fluctuations in Parkinson's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
Title: Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
Journal: Pharmacotherapy 20071201
Title: Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.
Journal: Annals of the New York Academy of Sciences 20071201
Title: Parkinson disease: an incremental challenge.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association 20071201
Title: Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.
Journal: Journal of neurochemistry 20071001
Title: Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway.
Journal: Neurochemical research 20071001
Title: Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Journal: Clinical therapeutics 20070901
Title: The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Journal: Molecular pharmacology 20070601
Title: Rasagiline as a therapy for Parkinson's disease (PD).
Journal: The American journal of geriatric pharmacotherapy 20070601
Title: Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
Journal: Neurobiology of disease 20070101
Title: Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20070101
Title: Rasagiline: a review of its use in the management of Parkinson's disease.
Journal: Drugs 20070101
Title: Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
Journal: Drugs & aging 20070101
Title: Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers.
Journal: Journal of neural transmission. Supplementum 20070101
Title: Rasagiline (Azilect) for Parkinson's disease.
Journal: The Medical letter on drugs and therapeutics 20061204
Title: L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
Journal: Pharmacology, biochemistry, and behavior 20061201
Title: The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Journal: Current Alzheimer research 20061201
Title: Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
Journal: The American journal of geriatric pharmacotherapy 20061201
Title: Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms.
Journal: Journal of the neurological sciences 20061025
Title: Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline.
Journal: Movement disorders : official journal of the Movement Disorder Society 20061001
Title: Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease.
Journal: Neurology 20060523
Title: Clinical trials with rasagiline: evidence for short-term and long-term effects.
Journal: Neurology 20060523
Title: Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060515
Title: [Diagnosis and therapy of idiopathic Parkinson's disease].
Journal: MMW Fortschritte der Medizin 20060515
Title: Safety of rasagiline in elderly patients with Parkinson disease.
Journal: Neurology 20060509
Title: Rasagiline improves quality of life in patients with early Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20060501
Title: Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
Journal: The Annals of pharmacotherapy 20060401
Title: Rasagiline -- is there a place for this drug in managing Parkinson's disease?
Journal: International journal of clinical practice 20060201
Title: Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease.
Journal: International journal of clinical practice 20060201
Title: Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness.
Journal: British journal of pharmacology 20060101
Title: Concerning neuroprotective therapy for Parkinson's disease.
Journal: Journal of neural transmission. Supplementum 20060101
Title: Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety.
Journal: Journal of neural transmission. Supplementum 20060101
Title: New drugs: rasagiline mesylate, conivaptan hydrochloride, and sunitinib malate.
Journal: Journal of the American Pharmacists Association : JAPhA 20060101
Title: New drug treatment for Parkinson's disease.
Journal: FDA consumer 20060101
Title: Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
Journal: Journal of neural transmission. Supplementum 20060101
Title: The use of rasagiline in Parkinson's disease.
Journal: Journal of neural transmission. Supplementum 20060101
Title: Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis.
Journal: Journal of medicinal chemistry 20051229
Title: Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20051101
Title: Present and future drug treatment for Parkinson's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20051101
Title: Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
Journal: Expert review of neurotherapeutics 20051101
Title: Rasagiline in the pharmacotherapy of Parkinson's disease--a review.
Journal: Expert opinion on pharmacotherapy 20051001
Title: In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20051001
Title: [Rasagiline in motor fluctuations].
Journal: Fortschritte der Neurologie-Psychiatrie 20050901
Title: Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20050801
Title: Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease.
Journal: Journal of clinical pharmacology 20050801
Title: Reexamination of the TEMPO Study.
Journal: Archives of neurology 20050801
Title: Rasagiline.
Journal: Nature reviews. Drug discovery 20050801
Title: Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway.
Journal: Annals of the New York Academy of Sciences 20050801
Title: [Rasagiline. A new monoamine oxidase b inhibitor for Parkinson treatment].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20050701
Title: Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.
Journal: Drugs of today (Barcelona, Spain : 1998) 20050601
Title: Parkinson's disease. Diagnosis and the initiation of therapy.
Journal: Minerva medica 20050601
Title: Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Journal: Movement disorders : official journal of the Movement Disorder Society 20050501
Title: Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.
Journal: Brain research. Brain research reviews 20050401
Title: Novel pharmacological strategies for motor complications in Parkinson's disease.
Journal: Expert opinion on investigational drugs 20050401
Title: Characterization of the neuroprotective activity of rasagiline in cerebellar granule cells.
Journal: Neuropharmacology 20050301
Title: Rasagiline for motor complications in Parkinson's disease.
Journal: Lancet (London, England) 20050301
Title: Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Journal: Lancet (London, England) 20050301
Title: Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Journal: Mechanisms of ageing and development 20050201
Title: A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
Journal: Archives of neurology 20050201
Title: Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition.
Journal: Journal of neuroscience research 20050101
Title: Movement disorders: understanding clinical trials.
Journal: The Lancet. Neurology 20050101
Title: Rasagiline.
Journal: Drugs & aging 20050101
Title: Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy.
Journal: Movement disorders : official journal of the Movement Disorder Society 20050101
Title: Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?
Journal: CNS drug reviews 20050101
Title: [The early therapy challenge].
Journal: Krankenpflege Journal 20050101
Title: [Are there innovations in the treatment of Parkinson's disease?].
Journal: Praxis 20041103
Title: Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease.
Journal: Neurology 20041012
Title: Clinical trials of neuroprotection for Parkinson's disease.
Journal: Neurology 20041012
Title: Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.
Journal: British journal of pharmacology 20041001
Title: Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20041001
Title: Tolerability, safety, pharmacodynamics, and pharmacokinetics of rasagiline: a potent, selective, and irreversible monoamine oxidase type B inhibitor.
Journal: Pharmacotherapy 20041001
Title: Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040901
Title: Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
Journal: Journal of neurology 20040901
Title: Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
Journal: Movement disorders : official journal of the Movement Disorder Society 20040801
Title: Rasagiline enhances L-DOPA-induced contralateral turning in the unilateral 6-hydroxydopamine-lesioned guinea-pig.
Journal: Neuropharmacology 20040701
Title: Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease.
Journal: Experimental neurology 20040601
Title: Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo.
Journal: Journal of neurochemistry 20040601
Title: N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor.
Journal: Neurochemistry international 20040501
Title: A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease.
Journal: Archives of neurology 20040401
Title: Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues.
Journal: Journal of medicinal chemistry 20040325
Title: Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class.
Journal: Journal of medicinal chemistry 20040325
Title: Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline.
Journal: Neuroscience letters 20040130
Title: Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology 20040101
Title: The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20031201
Title: The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline.
Journal: Biochemical pharmacology 20031015
Title: Amyloid processing and signal transduction properties of antiparkinson-antialzheimer neuroprotective drugs rasagiline and TV3326.
Journal: Annals of the New York Academy of Sciences 20030501
Title: Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline.
Journal: Journal of enzyme inhibition and medicinal chemistry 20030401
Title: Monoamine oxidase inhibitors--is it time to up the TEMPO?
Journal: The Lancet. Neurology 20030301
Title: A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.
Journal: Archives of neurology 20021201
Title: Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours.
Journal: Neuropharmacology 20021201
Title: Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20021001
Title: Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan.
Journal: Journal of neurochemistry 20020801
Title: Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
Journal: Movement disorders : official journal of the Movement Disorder Society 20020701
Title: An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells.
Journal: Neuroscience letters 20020628
Title: Rasagiline. Teva Pharmaceutical.
Journal: Current opinion in investigational drugs (London, England : 2000) 20020501
Title: Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuroprotection by propargylamines.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020501
Title: Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline.
Journal: Mechanisms of ageing and development 20020430
Title: The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020401
Title: Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.
Journal: Parkinsonism & related disorders 20020301
Title: Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].
Journal: Cellular and molecular neurobiology 20011201
Title: Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol.
Journal: Journal of neurochemistry 20010801
Title: Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
Journal: Annals of the New York Academy of Sciences 20010601
Title: Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022.
Journal: Annals of the New York Academy of Sciences 20010601
Title: The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo.
Journal: Annals of the New York Academy of Sciences 20010601
Title: Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
Journal: Annals of the New York Academy of Sciences 20010401
Title: Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
Journal: British journal of pharmacology 20010101
Title: Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20010101
Title: Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20010101
Title: Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
Journal: Journal of neural transmission. Supplementum 19980101
